Explore articles, research, and perspectives from the International Perfusion Association.
A prospective study of 94 CABG patients linked coronary sinus lactate above 3 mmol/L five minutes after reperfusion with more treated postoperative atrial fibrillation.
In 691 aortic surgery patients, post-bypass blood pressure and shock indices tracked 30-day mortality; exploratory thresholds require external validation.
A 155-pair study links miniAVR with fewer stroke/TIA events, but rare outcomes, residual confounding, and unequal follow-up limit causal conclusions.
A 76-patient randomized CABG trial links cuff deflation during bypass to smaller ultrasound airway changes, while clinical benefits and aspiration safety remain uncertain.
A 16-patient series examines planned Impella 5.5 support after high-risk cardiac surgery, highlighting feasibility, postoperative escalation, complications, and important reporting limitations.
Six randomized trials found no significant improvement in acute kidney injury or other clinical outcomes with intraoperative hemoadsorption. Trial sequential analysis shows that the
A retrospective comparison links femoral cannulation before redo sternotomy with lower red-cell use and fewer reported cardiovascular complications. Important inconsistencies in patient counts, follow-up,
A meta-analysis of seven randomized trials examines goal-directed perfusion, oxygen delivery, and cardiac index, with benefits for recovery and important evidence limitations.
A case report of temperature-dependent red-cell clumping during valve surgery highlights cold-agglutinin recognition, changes to bypass and cardioplegia, and the limits of single-patient evidence.
A 166-patient study links preoperative platelet-to-lymphocyte ratio with prolonged inotropic support after minimally invasive cardiac surgery. Predictive performance was modest.
A study combines clinical prediction models with experimental evidence linking lactate metabolism and kidney injury after CPB. Clinical treatment benefit remains unproven.
A 76-neonate randomized trial compared initial heparin doses during CPB. Higher initial dosing improved ACT response and a thrombin-generation marker, but clinical benefit and
